The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

OBJECTIVE: To assess outcomes for patients treated with interferon beta-1b immediately after clinically isolated syndrome (CIS) or after a short delay. METHODS: Participants in BENEFIT (Betaferon/Betaseron in Newly Emerging MS for Initial Treatment) were randomly assigned to receive interferon beta-...

Descripción completa

Detalles Bibliográficos
Autores principales: Kappos, Ludwig, Edan, Gilles, Freedman, Mark S., Montalbán, Xavier, Hartung, Hans-Peter, Hemmer, Bernhard, Fox, Edward J., Barkhof, Frederik, Schippling, Sven, Schulze, Andrea, Pleimes, Dirk, Pohl, Christoph, Sandbrink, Rupert, Suarez, Gustavo, Wicklein, Eva-Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027814/
https://www.ncbi.nlm.nih.gov/pubmed/27511182
http://dx.doi.org/10.1212/WNL.0000000000003078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027814/
https://www.ncbi.nlm.nih.gov/pubmed/27511182
http://dx.doi.org/10.1212/WNL.0000000000003078

Ejemplares similares